Atlas Trials

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

Clinical trial NCT05371132 · RECRUITING

Trial details

NCT number
NCT05371132
Sponsor
City of Hope Medical Center
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Malignant Solid NeoplasmLymphoma
Start date
2022-06-20
Primary completion
2026-10-05
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.